张超 (教授)

教授   博士生导师   硕士生导师

性别:男

毕业院校:大连理工大学

学位:博士

所在单位:数学科学学院

学科:计算数学

办公地点:创新园#A1024

联系方式:0411-84708351

电子邮箱:chao.zhang@dlut.edu.cn

Identification of herbal categories active in pain disorder subtypes by machine learning help reveal novel molecular mechanisms of algesia

点击次数:

论文类型:期刊论文

发表时间:2020-04-08

发表刊物:Pharmacological research

收录刊物:PubMed

页面范围:104797

ISSN号:1096-1186

关键字:cancer pain,complex network analysis,network pharmacology,pain disorder subtypes

摘要:Chronic pain is highly prevalent and poorly controlled, of which the accurate underlying mechanisms need be further elucidated. Herbal drugs have been widely used for controlling various pain disorders. The systematic integration of pain herbal data resources might be promising to help investigate the molecular mechanisms of pain phenotypes. Here, we integrated large-scale bibliographic literatures and well-established data sources to obtain high-quality pain relevant herbal data (i.e. 426 pain related herbs with their targets). We used machine learn method to identify three distinct herb categories with their specific indications of symptoms, targets and enriched pathways, which were characterized by the efficacy of treatment to the chronic cough related neuropathic pain, the reproduction and autoimmune related pain, and the cancer pain, respectively. We further detected the novel pathophysiological mechanisms of the pain subtypes by network medicine approach to evaluate the interactions between herb targets and the pain disease modules. This work increased the understanding of the underlying molecular mechanisms of pain subtypes that herbal drugs are participating and with the ultimate aim of developing novel personalized drugs for pain disorders.Copyright © 2020. Published by Elsevier Ltd.

发表时间:2020-04-08

上一条: Identification of herbal categories active in pain disorder subtypes by machine learning help reveal novel molecular mechanisms of algesia

下一条: Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk